Artrya Limited (AYA.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 03:03PM AEST
Artrya Limited
1257 Hay Street
West Perth, WA 6005
Australia
61 8 6478 7816
https://www.artrya.com
Sector(s): Healthcare
Industry: Health Information Services
Full-time employees:
Key executives
| Name | Title | Pay | Exercised | Year born |
|---|---|---|---|---|
| Mr. Mathew Regan | Chief Executive Officer | 460.49k | N/A | N/A |
| Mr. John Konstantopoulos B.E. | Co-Founder and Executive of Commercial & Strategy | 287.46k | N/A | N/A |
| Mr. Mark Wainwright | Chief Financial Officer | N/A | N/A | N/A |
| Prof. Girish Dwivedi M.D. | Chief Scientific Officer | N/A | N/A | N/A |
| Mr. Ted Schwab | Co-CEO of Artrya USA Inc | N/A | N/A | N/A |
| Mr. Kevin Ronald Hart B.Com., B.Comm (Hons), C.A., F.C.A. | Company Secretary | N/A | N/A | 1962 |
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
Description
Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.
Corporate governance
Artrya Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.
© 2024 Yahoo. All rights reserved.